Investors watch Nuvalent ahead of pivotal neladalkib ALKOVE-1 topline data in resistant ALK-positive NSCLC
Nuvalent will unveil pivotal ALKOVE-1 data for neladalkib in TKI-pretreated ALK-positive NSCLC on November 17. Explore why investors believe this readout could redefine targeted lung ... Read More
FDA lifts hold on Rein Therapeutics’ LTI-03 trial, reviving hopes for idiopathic pulmonary fibrosis treatment
FDA clears Rein Therapeutics to restart its Phase 2 trial of LTI-03 for idiopathic pulmonary fibrosis, restoring investor confidence and trial momentum. Read More
Bioxytran reports successful clinical trial for ProLectin-M, a broad-spectrum antiviral targeting multiple respiratory viruses
Find out how Bioxytran’s completed randomized trial for ProLectin-M could redefine the antiviral market and reshape biotech investor sentiment. Read More
Denifanstat phase 3 acne trial success positions Ascletis for China NDA submission in 2026
Find out how Denifanstat’s Phase 3 acne trial success positions Ascletis Pharma for a 2026 China NDA submission and reshapes the acne-therapy market. Read More
FDA greenlights Envoy Medical’s fully implanted cochlear implant trial — could this be the biggest leap in hearing restoration yet?
Find out how Envoy Medical’s FDA-cleared Acclaim cochlear implant trial is redefining the future of fully implanted hearing technology. Read More
Bonerge initiates clinical trial evaluating Urolithin A and Fisetin for age-related sleep disruptions
Bonerge begins a clinical trial on Urolithin A and Fisetin for sleep quality, marking a shift toward evidence-backed anti-ageing and circadian rhythm restoration. Read More
PharmaJet and Immuno Cure partner to launch needle-free HIV therapeutic DNA vaccine trial using Tropis intradermal device
PharmaJet and Immuno Cure sign agreement to use the Tropis intradermal system in a needle-free human trial for a promising HIV DNA vaccine candidate. Read More
Abbott’s Healthy Food Rx program shows clinical benefits for diabetes patients in low-income settings
Abbott’s Healthy Food Rx clinical trial improves diet, A1C levels, and health in underserved diabetes patients, advancing the food-is-medicine model in the U.S. Read More
Smart insulin system improves glucose control for pregnant women with type 1 diabetes, according to ADA 2025 clinical trial findings
Smart insulin system shows improved glucose control in pregnancy with type 1 diabetes, per ADA 2025 trial; regulatory expansion expected. Read full details. Read More
Keymed Biosciences’ CM336 shows sustained remission in AIHA patients after CAR-T failure
Keymed Biosciences’ CM336 delivers 6-month remission in AIHA post-CAR-T failure, with NEJM publication and bullish stock sentiment. Find out what’s next for the biotech. Read More